Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

HeartSciences (HSCS) Accumulated Expenses (2022 - 2026)

HeartSciences (HSCS) has disclosed Accumulated Expenses for 4 consecutive years, with $311184.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Accumulated Expenses fell 15.82% year-over-year to $311184.0, compared with a TTM value of $311184.0 through Oct 2025, down 15.82%, and an annual FY2025 reading of $177628.0, down 33.92% over the prior year.
  • Accumulated Expenses was $311184.0 for Q4 2025 at HeartSciences, up from $251366.0 in the prior quarter.
  • Across five years, Accumulated Expenses topped out at $1.1 million in Q2 2022 and bottomed at $106726.0 in Q1 2025.
  • Average Accumulated Expenses over 4 years is $485657.9, with a median of $385857.0 recorded in 2023.
  • The sharpest move saw Accumulated Expenses rose 24.81% in 2023, then plummeted 81.74% in 2025.
  • Year by year, Accumulated Expenses stood at $890654.0 in 2022, then fell by 13.25% to $772670.0 in 2023, then plummeted by 52.16% to $369673.0 in 2024, then decreased by 15.82% to $311184.0 in 2025.
  • Business Quant data shows Accumulated Expenses for HSCS at $311184.0 in Q4 2025, $251366.0 in Q3 2025, and $177628.0 in Q2 2025.